PPC
PFE icon

Park Place Capital’s Pfizer PFE Stock Holding History

Park Place Capital’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$741K Buy
30,792
+8,791
+40% +$230K 0.12% 114
2026
Q1 		$618K Sell
22,001
-4,712
-18% -$125K 0.12% 105
2025
Q4 		$665K Sell
26,713
-37,733
-59% -$952K 0.14% 102
2025
Q3 		$1.64M Buy
64,446
+7,763
+14% +$192K 0.35% 50
2025
Q2 		$1.42M Buy
56,683
+43,479
+329% +$1.01M 0.32% 59
2025
Q1 		$335K Buy
13,204
+5,616
+74% +$147K 0.09% 142
2024
Q4 		$201K Sell
7,588
-4,430
-37% -$120K 0.06% 197
2024
Q3 		$348K Sell
12,018
-2,201
-15% -$64.2K 0.1% 163
2024
Q2 		$398K Sell
14,219
-4,351
-23% -$120K 0.13% 152
2024
Q1 		$515K Buy
18,570
+756
+4% +$21K 0.18% 134
2023
Q4 		$513K Sell
17,814
-3,169
-15% -$95.8K 0.2% 134
2023
Q3 		$696K Sell
20,983
-425
-2% -$15K 0.2% 122
2023
Q2 		$785K Buy
21,408
+693
+3% +$27K 0.22% 112
2023
Q1 		$845K Buy
20,715
+3,504
+20% +$151K 0.24% 97
2022
Q4 		$882K Buy
+17,211
New +$825K 0.25% 94

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Park Place Capital's PFE Position: Q2 2026 in Review

Park Place Capital increased its Pfizer (PFE) stake by 40% in Q2 2026, buying an estimated $230K and bringing the position to 30,792 shares worth $741K. The position accounts for 0.12% of the portfolio, ranked #114.

Park Place Capital first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.64M in Q3 2025. 2,826 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Park Place Capital held 30,792 shares of Pfizer worth $741K as of Q2 2026.
  • Park Place Capital bought 8,791 Pfizer shares in Q2 2026, an estimated $230K.
  • Pfizer made up 0.12% of Park Place Capital's portfolio in Q2 2026, its #114 holding.
  • Park Place Capital first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Park Place Capital's Pfizer position peaked at $1.64M in Q3 2025.
  • 2,826 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.